Scientific Advisory Board(SAB)
René Bernards, Ph.D.
Professional Experience
- 2019 - Present Shanghai Jiao Tong University, Professor of Molecular Carcinogenesis
- 2017 – Present Oncode Institute, Founding Member
- 2017 – Present Oncosence BV., Co-founder
- 2015 – Present Netherlands Cancer Institute, Senior Staff Scientist
- 2015 – Present Qameleon Therapeutics BV., Co-founder
- 2014 – 2015 Genentech Inc., Visiting Scientist
- 2003 – Present Agendia NV, Co-founder and Chief Scientific Officer
- 1994 – Present Utrecht University, Professor of Molecular Carcinogenesis
- 1992 – 2015 Netherlands Cancer Institute, Head of Molecular Carcinogenesis Division
- 1988 – 1994 Harvard University, Assistant Professor
- 1985 – 1988 Whitehead Institute for Biomedical Research, Laboratory of Robert Weinberg, Post-doctoral Fellow
Education
- University of Leiden, Molecular Biology, Ph.D.
- University of Amsterdam, Molecular Biology, M.Sc.
- University of Amsterdam, Medical Biology, B.S.
